Abstract
Glutamatergic dysregulation has been hypothesized to play a role in schizophrenia. The N-methyl-D-aspartate (NMDA) type of glutamate receptor especially is of interest because, in addition to binding sites for glutamate and glycine, a necessary co-agonist, this receptor also contains noncompetitive binding sites for the psychotomimetics phencyclidine (PCP), MK-801, and ketamine. PCP-induced psychosis has been a useful disease model in that both the positive as well as the negative symptomatologies seen in schizophrenia are observed. Recently, a mouse deficient in expression of the NR1 subunit gene (NMDAR1) of the heteromeric receptor has been developed and shown to display aberrant behaviors, with reduced social and sexual interactions as well as increased stereotypic motor activity. In an extensive examination of the NMDAR1 gene in our laboratory in approximately 100 chronic schizophrenic patients, 28 unique sequence changes were identified, including eight single nucleotide polymorphisms (SNPs) in the 5′ untranslated region (5′UTR), six SNPs in coding regions (cSNPs), eleven intronic SNPs, two intronic deletions of 7 and 30 bp, and an intronic microinsertion/deletion. With the exception of one previously reported cSNP, all of the identified changes were novel. The frequency of polymorphisms differed significantly by ethnicity and several appeared to be in linkage disequilibrium. None of the changes appeared likely to be of functional significance, thus suggesting that changes in the genomic NMDAR1 are unlikely to contribute to the etiology of schizophrenia. Estimates of nucleotide diversity are comparable to those observed in studies of other genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wood MW, VanDongen HMA, VanDongen AMJ . The 5′-untranslated region of the n-methyl-d-aspartate receptor. NR2A subunit controls efficiency of translation J Biol Chem 1996 271: 8115–8120
Laube B, Kuhse J, Betz H . Evidence for a tetrameric structure of recombinant NMDA receptors J Neurosci 1998 18: 2954–2961
Tamminga CA . Schizophrenia and glutamatergic transmission Crit Rev Neurobiol 1998 12: 21–36
Javitt DC, Zukin SR . Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 1991 148: 1301–1308
Kandel E . Disorders of thought: schizophrenia. In: Kandel ER, Schwartz JH, Jessell TM (eds) Principles of Neural Science 3rd edn: Elsevier Press, New York 1991 p 866
Malhotra A . Park City Molecular Psychiatry Conference, Feb 2–4, 1997 Meeting report: Psych Genet 1997 7: 53–56
Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A Nature 1998 393: 377–381
Hollmann M, Heinemann S . Cloned glutamate receptors Annu Rev Neurosci 1994 17: 31–108
Mohn AR, Gainetdinov RR, Caron MG, Koller BH . Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 1999 98: 427–436
Sobell J, Heston L, Sommer S . Novel association approach for determining the genetic predisposition to schizophrenia: case-control resource and testing of a candidate gene Am J Med Genet (Neuropsych Genet) 1993 48: 28–35
Sobell JL, Lind TJ, Sigurdson DC, Zald DH, Snitz BE, Grove WM et al. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense mutation and multiple missense changes but lack of association with disease Hum Mol Genet 1995 4: 507–514
Kurland LT, Molgaard CA . The patient record in epidemiology Sci Am 1981 245: 54–63
Liu Q, Feng J, Sommer S . Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300–600 bp Hum Mol Genet 1996 5: 107–114
Sarkar G, Yoon H-S, Sommer S . Dideoxy fingerprinting (ddF): a rapid and efficient screen for the presence of mutations Genomics 1992 13: 441–443
Liu Q, Sommer S . Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP PCR Meth Applic 1994 4: 97–108
Lancaster JM, Berchuck A, Futreal PA, Wiseman RW . Dideoxy fingerprinting assay for BRCA1 mutation analysis Mol Carcinog 1997 19: 176–179
Puck JM, Middelton L, Pepper AE . Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: mutation detection methods and utilization Hum Genet 1997 99: 628–633
Quandt K, Frech K, Karas H, Wingender E, Werner T . MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data Nucleic Acids Res 1995 23: 4878–4884
Kolchanov NA, Ponomarenko MP, Frolov AS, Ananko EA, Kolpakov FA, Ignatieva EV et al. Integrated databases and computer systems for studying eurkaryotic gene expression Bioinformatics 1999 15: 669–686
Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL Nucleic Acids Res 1998 26: 364–370
Li W-H . Molecular Evolution Sinauer Associates, Sunderland, MA 1997 pp 237–238
Halushka MK, Fan J-B, Bentley K, Hsie L, Shen N, Weder A et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis Nat Genet 1999 22: 239–247
D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM-Y, Bird TD et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements Proc Natl Acad Sci USA 1999 96: 5598–5603
Chew SL, Liu HX, Mayeda A, Krainer AR . Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing Proc Natl Acad Sci USA 1999 96: 10655–10660
Kuo BA, Norton PA . Accurate selection of a 5′ splice site requires sequences within fibronectin alternative exon B Nucl Acid Res 1999 27: 3945–3952
Modafferi EF, Black DL . Combinatorial control of a neuron-specific exon RNA 1999 5: 687–706
Liu W, Qian C, Francke U . Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome Nat Genet 1997 16: 328–329
Myers SJ, Dingledine R, Borges K . Genetic regulation of glutamate receptor ion channels Annu Rev Pharmacol Toxicol 1999 39: 221–241
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes Nat Genet 1999 22: 231–238
Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene Nat Genet 1998 3: 233–240
Acknowledgements
This work was supported in part by grants from the National Alliance for Research on Schizophrenia and Depression (NARSAD), the National Institute of Mental Health (MH54232), and the Beckman Research Institute at the City of Hope National Medical Center. We graciously thank all research participants and acknowledge the support and cooperation of staff from the Mayo Clinic (MN), Zumbro Valley Mental Health Center (MN), St Peter Regional Treatment Center (MN), Anoka-Metro Regional Treatment Center (MN), Western and Eastern State Hospitals (WA), and Dammasch State Hospital (OR).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rice, S., Niu, N., Berman, D. et al. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol Psychiatry 6, 274–284 (2001). https://doi.org/10.1038/sj.mp.4000838
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000838
Keywords
This article is cited by
-
Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment
Pharmacological Reports (2021)
-
Association between polymorphisms in the GRIN1 gene 5′ regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro
BMC Medical Genetics (2019)
-
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
Psychopharmacology (2015)
-
Association Between the G1001C Polymorphism in the GRIN1 Gene Promoter and Schizophrenia in the Iranian Population
Journal of Molecular Neuroscience (2009)
-
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
Psychopharmacology (2008)